Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,400.00 at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its price objective boosted by Wells Fargo & Company from $1,350.00 to $1,400.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have an equal weight rating on the medical instruments supplier’s stock.

MTD has been the topic of several other research reports. Wolfe Research initiated coverage on Mettler-Toledo International in a research report on Friday, December 13th. They issued a “peer perform” rating on the stock. Stifel Nicolaus dropped their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Robert W. Baird boosted their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research report on Monday. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Finally, Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and boosted their price target for the company from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and an average target price of $1,368.00.

Mettler-Toledo International Stock Performance

MTD opened at $1,313.20 on Monday. The business’s 50-day simple moving average is $1,281.95 and its 200-day simple moving average is $1,341.62. Mettler-Toledo International has a one year low of $1,133.46 and a one year high of $1,546.93. The stock has a market capitalization of $27.71 billion, a P/E ratio of 32.40, a price-to-earnings-growth ratio of 4.80 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 564.51% and a net margin of 22.29%. On average, equities research analysts forecast that Mettler-Toledo International will post 41.94 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the sale, the insider now owns 6 shares of the company’s stock, valued at $8,108.04. The trade was a 99.01 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.94% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several institutional investors have recently modified their holdings of MTD. Sanctuary Advisors LLC purchased a new stake in shares of Mettler-Toledo International during the 2nd quarter worth approximately $500,000. Wedmont Private Capital purchased a new stake in shares of Mettler-Toledo International during the 3rd quarter worth approximately $246,000. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Mettler-Toledo International by 400.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 125 shares of the medical instruments supplier’s stock worth $187,000 after acquiring an additional 100 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in shares of Mettler-Toledo International by 2,300.0% during the 3rd quarter. Exchange Traded Concepts LLC now owns 144 shares of the medical instruments supplier’s stock worth $216,000 after acquiring an additional 138 shares in the last quarter. Finally, Koshinski Asset Management Inc. boosted its stake in shares of Mettler-Toledo International by 40.0% during the 3rd quarter. Koshinski Asset Management Inc. now owns 322 shares of the medical instruments supplier’s stock worth $483,000 after acquiring an additional 92 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.